Target intelligence / Profile preview

Ankyrin repeat and SOCS box protein 18 (ASB18)

Target
ASB18
Molecular classification
Other (Ankyrin repeat-containing protein; SOCS box family; adapter/scaffold protein)
01

Overview

Ankyrin repeat and SOCS box protein 18 (ASB18) is a member of the ankyrin repeat and SOCS (suppressor of cytokine signaling) box-containing (ASB) protein family in humans. Members of this protein family contain N-terminal ankyrin repeat domains—motifs known for mediating protein-protein interactions—and a C-terminal SOCS box, which can recruit components of an E3 ubiquitin ligase complex. ASB18 is thought to function as a substrate-recognition subunit of a SCF-like ECS (Elongin-Cullin-SOCS-box) E3 ubiquitin-protein ligase complex, mediating polyubiquitination and subsequent proteasomal degradation of target proteins[1][3][7]. There is currently no direct evidence linking ASB18 with specific diseases, nor are there known drugs or inhibitors directly targeting ASB18. It is not classified as a major therapeutic target (such as a receptor, enzyme, or transporter), but may play a supporting role in ubiquitin-dependent protein degradation[1][3][7]. The UniProtKB/Swiss-Prot accession for human ASB18 is Q6ZVZ8[1][7].

Other names
ASB-18Ankyrin repeat and SOCS box-containing 18ankyrin repeat and SOCS box protein 18
02

Biological functions

Protein-protein interactionComponent of E3 ubiquitin ligase complexProtein ubiquitination
03

Disease associations

Other (no strong disease association currently established)

Beyond the preview

Go deeper on Ankyrin repeat and SOCS box protein 18 (ASB18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and SOCS box protein 18 (ASB18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call